And many children refused to complete neuroapthy test. Update Diabetic neuropathy in children the management of diabetic neuropathy. Mayo Clinic Press Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.

Diabetic neuropathy in children -

Diabetes history. The risk of diabetic neuropathy increases the longer a person has diabetes, especially if blood sugar isn't well controlled. Kidney disease. Diabetes can damage the kidneys. Kidney damage sends toxins into the blood, which can lead to nerve damage. Being overweight. Having a body mass index BMI of 25 or more may increase the risk of diabetic neuropathy.

Smoking narrows and hardens the arteries, reducing blood flow to the legs and feet. This makes it more difficult for wounds to heal and damages the peripheral nerves. Diabetic neuropathy can cause a number of serious complications, including: Hypoglycemia unawareness.

But people who have autonomic neuropathy may not experience these warning signs. Loss of a toe, foot or leg. Nerve damage can cause a loss of feeling in the feet, so even minor cuts can turn into sores or ulcers without being noticed.

In severe cases, an infection can spread to the bone or lead to tissue death. Removal amputation of a toe, foot or even part of the leg may be necessary. Urinary tract infections and urinary incontinence. If the nerves that control the bladder are damaged, the bladder may not empty completely when urinating.

Bacteria can build up in the bladder and kidneys, causing urinary tract infections. Nerve damage can also affect the ability to feel the need to urinate or to control the muscles that release urine, leading to leakage incontinence. Sharp drops in blood pressure. Damage to the nerves that control blood flow can affect the body's ability to adjust blood pressure.

This can cause a sharp drop in pressure when standing after sitting or lying down, which may lead to lightheadedness and fainting. Digestive problems. If nerve damage occurs in the digestive tract, constipation or diarrhea, or both are possible.

Diabetes-related nerve damage can lead to gastroparesis, a condition in which the stomach empties too slowly or not at all. This can cause bloating and indigestion.

Sexual dysfunction. Autonomic neuropathy often damages the nerves that affect the sex organs. Men may experience erectile dysfunction.

Women may have difficulty with lubrication and arousal. Increased or decreased sweating. Nerve damage can disrupt how the sweat glands work and make it difficult for the body to control its temperature properly.

Blood sugar management The American Diabetes Association ADA recommends that people living with diabetes have a glycated hemoglobin A1C test at least twice a year.

Foot care Foot problems, including sores that don't heal, ulcers and even amputation, are common complications of diabetic neuropathy.

To protect the health of your feet: Check your feet every day. Look for blisters, cuts, bruises, cracked and peeling skin, redness, and swelling.

Use a mirror or ask a friend or family member to help examine parts of your feet that are hard to see. Keep your feet clean and dry. Wash your feet every day with lukewarm water and mild soap.

Don't soak your feet. Dry your feet and between your toes thoroughly. Moisturize your feet. This helps prevent cracking. But don't get lotion between your toes because it might encourage fungal growth. Trim your toenails carefully. Cut your toenails straight across. File the edges carefully so that you have smooth edges.

If you can't do this yourself, a specialist in foot problems podiatrist can help. Wear clean, dry socks. Look for socks made of cotton or moisture-wicking fibers that don't have tight bands or thick seams.

Wear cushioned shoes that fit well. Wear closed-toed shoes or slippers to protect your feet. Make sure your shoes fit properly and allow your toes to move. A foot specialist can teach you how to buy properly fitted shoes and to prevent problems such as corns and calluses.

If you qualify for Medicare, your plan may cover the cost of at least one pair of shoes each year. By Mayo Clinic Staff. Apr 29, Show References. Ferri FF. Diabetic polyneuropathy.

In: Ferri's Clinical Advisor Elsevier; Accessed Dec. Diabetic neuropathy. National Institute of Diabetes and Digestive and Kidney Diseases. Accessed Jan. American Diabetes Association. Standards of medical care in diabetes — Diabetes Care. Accessed Nov.

Peripheral neuropathy adult. Mayo Clinic; Feldman EL, et al. Management of diabetic neuropathy. Diabetes and foot problems. Jankovic J, et al. Disorders of peripheral nerves. In: Bradley and Daroff's Neurology in Clinical Practice.

Baute V, et al. Complementary and alternative medicine for painful peripheral neuropathy. Current Treatment Options in Neurology. Nature Reviews — Disease Primers. Cutsforth-Gregory expert opinion. Mayo Clinic. Castro MR expert opinion. Diabetic neuropathy and dietary supplements.

Associated Procedures. Electromyography EMG. Show the heart some love! Give Today. Help us advance cardiovascular medicine. Find a doctor. Explore careers. Snahnicanova Z, Mendelova A, Grendar M, et al. Genet Test Mol Biomarkers 22 7 — Al-Taweela YA, Fahmia RM, Shehtaa N, et al. Egyptian J Neurol Psychiatry Neurosurg 53 4 Craig ME, Duffin AC, Gallego PH, et al.

Diabetes Care 31 6 — Wever A, Schickenberg-Werrij BG, Willems J, Schaper NC, Schott DA Prevalence and awareness of functional and structural foot abnormalities in children and adolescents with type 1 diabetes.

J Pediatr Endocrinol Metab 29 9 — Billow A, Anjana RM, Ngai M, et al. J Diabetes Complications 29 5 — Toopchizadeh V, Shiva S, Khiabani NY, Ghergherechi R Electrophysiologic pattern and prevalence of subclinical peripheral neuropathy in children and adolescents with type I diabetes mellitus in Iran.

Saudi Med J 37 3 — Jaiswal M, Urbina EM, Wadwa RP, et al. Diabetes Care 36 1 — Louraki M, Katsalouli M, Kanaka-Gantenbein C, et al. Diabetes Res Clin Pract — Moser JT, Langdon DR, Finkel RS, et al.

Diabetes Res Clin Pract 1 :e Metwalley KA, Hamed SA, Farghaly HS Cardiac autonomic function in children with type 1 diabetes. Eur J Pediatr 6 — Cho YH, Craig ME, Jopling T, Chan A, Donaghue KC Higher body mass index predicts cardiac autonomic dysfunction: A longitudinal study in adolescent type 1 diabetes.

Cho YH, Craig ME, Srinivasan S, et al. Clin Endocrinol Oxf 80 6 — Dyck PJ, Bushek W, Spring EM et al. Diabetes Care 10 4 — Gentile S, Turco S, Corigliano G, Marmo R Simplified diagnostic criteria for diabetic distal polyneuropathy Preliminary data of a multicentre study in the Campania region.

Acta Diabetol 32 1 :7— Herman WH, Pop-Busui R, Braffett BH et al. Diabet Med 29 7 — Cruz-Almeida Y, Fillingim RB Can quantitative sensory testing move us closer to mechanism-based pain management? Pain Med 15 1 — Baba M, Matsui N, Kuroha M, Wasaki Y, Ohwada S Mirogabalin for the treatment of diabetic peripheral neuropathic pain: A randomized, double-blind, placebo-controlled phase III study in Asian patients.

J Diabetes Investig 10 5 — Wahren J, Foyt H, Daniels M, Arezzo JC Long-Acting C-Peptide and Neuropathy in Type 1 Diabetes: A Month Clinical Trial. Diabetes Care 39 4 — Mu Y, Liu X, Li Q, et al. J Diabetes 10 3 — Fensom B, Harris C, Thompson SE, Al Mehthel M, Thompson DM Islet cell transplantation improves nerve conduction velocity in type 1 diabetes compared with intensive medical therapy over six years.

Brown S, Johnston B, Amaria K, et al. Scand J Pain — Fraser DA, Diep LM, Hovden IA, et al. Diabetes Care 35 5 — Sun J, Wang Y, Zhang X, Zhu S, He H Prevalence of peripheral neuropathy in patients with diabetes: A systematic review and meta-analysis.

Prim Care Diabetes 14 5 — Akinci G, Savelieff MG, Gallagher G, Callaghan BC, Feldman EL Diabetic neuropathy in children and youth: New and emerging risk factors. Pediatr Diabetes 22 2 — Hirschfeld G, von Glischinski M, Blankenburg M, Zernikow B Screening for peripheral neuropathies in children with diabetes: a systematic review.

Pediatrics 5 :e—e Tang M, Donaghue KC, Cho YH, Craig ME Autonomic neuropathy in young people with type 1 diabetes: a systematic review. Pediatr Diabetes 14 4 — Vasigh A, Abdi A, Borji M, Tarjoman A The prevalence of neuropathy among type 1 diabetic adolescents in Iran: a systematic review and meta-analysis.

Int J Adolesc Med Health. Download references. Pediatric Diabetology Unit, Pediatric Department, S. Department of Translational Medical Science, Section of Pediatrics, Regional Center of Pediatric Diabetes, Federico II University of Naples, Naples, Italy. Section of Pediatric Diabetes and Metabolism, Department of Surgery, Dentistry, Gynecology and Pediatrics, University and Azienda Ospedaliera, Universitaria Integrata of Verona, Verona, Italy.

Department of Paediatrics, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. You can also search for this author in PubMed Google Scholar. RF, EM, MLM conceived the study. RF and EM made a substantial contribution to the design of this literature review and screened abstracts.

FDC, FR, LL, AL, FM, CAP conducted the full paper analysis. EM and RF independently assessed the certainty of the evidence for each of the outcomes. MLM resolved discrepancies. VC, AF, MLM wrote the manuscript. All the authors approved the final version of the manuscript.

Correspondence to Roberto Franceschi. This article does not contain any studies with human participants performed by any of the authors. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reprints and permissions. Franceschi, R. et al. A systematic review of the prevalence, risk factors and screening tools for autonomic and diabetic peripheral neuropathy in children, adolescents and young adults with type 1 diabetes. Acta Diabetol 59 , — Download citation. Received : 14 November Accepted : 09 January Published : 28 January Issue Date : March Anyone you share the following link with will be able to read this content:.

Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Abstract Aims We aimed to estimate the prevalence of Diabetic peripheral neuropathy DPN and Cardiac autonomic neuropathy CAN in youth with type 1 diabetes; identify key risk factors; identify the most useful tests for the diagnostic evaluation of DPN and CAN; identify key treatment options for DPN and CAN.

Methods A systematic search was performed including studies published in the last 15 years. Results A total of studies were identified and a final number of 49 studies were included in this systematic review. Conclusions Prevalence of neuropathy in youth with type 1 diabetes varies depending on different screening methods and characteristics of the study populations.

Access this article Log in via an institution. Data availability All databases generated for this study are included in the article. Abbreviations T1D: Type 1 diabetes T2D: Type 2 diabetes DKA: Diabetic ketoacidosis DN: Diabetic neuropathy DPN: Diabetic peripheral neuropathy NDS: Neuropathy disability score NSS: Neuropathy symptom score QST: Quantitative sensory testing VPT: Vibration perception threshold TT: Thermal threshold VT: Vibration threshold MNSI: Michigan neuropathy screening instrument examination NCS: Nerve conduction studies NCV: Nerve conduction velocity EMG: Electromyography SD: Standard deviation US: Ultrasound HbA1c: Hemoglobin A1c BMI SDS: Body mass index standard deviation score CAN: Cardiac autonomic neuropathy PAN GI: Gastrointestinal GP: Gastroparesis CARTs: Cardiovascular tests BP: Blood pressure BRS: Baroreflex sensitivity HR: Heart rate HRV: Heart rate variability ECG: Electrocardiography EDC: Pittsburgh epidemiology of diabetes complications.

References Graves LE, Donaghue KC Management of diabetes complications in youth. x Article PubMed Google Scholar Donaghue KC, Marcovecchio ML, Wadwa RP, et al.

x Article CAS PubMed Google Scholar Elbarbary NS, Ismail EAR, El-Hilaly RA, Ahmed FS Role of neopterin as a biochemical marker for peripheral neuropathy in pediatric patients with type 1 diabetes: Relation to nerve conduction studies. x Article CAS PubMed Google Scholar Ghaemi N, Hasanabadi H, Ashrafzadeh F, et al.

Iran J Child Neurol 12 2 —90 PubMed PubMed Central Google Scholar Hajas G, Kissova V, Tirpakova A A yr follow-up study for the detection of peripheral neuropathy in young patients with type 1 diabetes.

J Res Med Sci 18 2 — PubMed PubMed Central Google Scholar Elsamahy MH, Elbarbary NS, Elmorsi HM Current status of diabetes management, glycemic control and complications in children and adolescents with diabetes in Egypt Where do we stand now And where do we go from here.

Diabetes Res Clin Pract 3 — Article Google Scholar Christensen MMB, Hommel EE, Jørgensen ME, et al. x Article Google Scholar Cruz-Almeida Y, Fillingim RB Can quantitative sensory testing move us closer to mechanism-based pain management?

Funding The authors received no specific funding for this work. Author information Author notes Roberto Franceschi and Enza Mozzillo equally contributed to this work. Authors and Affiliations Pediatric Diabetology Unit, Pediatric Department, S.

Loredana Marcovecchio Authors Roberto Franceschi View author publications. View author publications. Ethics declarations Conflict of interest The authors have no financial or non-financial conflicts of interest to declare. Human and animal rights This article does not contain any studies with human participants performed by any of the authors.

Informed consent For this type of study, formal consent is not required.

Address Diabetic neuropathy in children correspondence: Taninee Sahakitrungruang Childrenn of Endocrinology, Chhildren of Pediatrics, Faculty of Diabetic neuropathy in children, Nduropathy University, BangkokDiabetic neuropathy in children Email: Chilvren. P chula. Purpose Diabetic neuropathy DN Cholesterol control for heart health a serious complication in diabetes mellitus. We aimed to determine the prevalence Gut health improvement DN in pediatric-onset diabetes in a tertiary care center and to assess the sensitivity and specificity of monofilament testing and noninvasive screening to diagnose DN compared with the gold standard nerve conduction study NCS. Methods Sixty-five Thai children and adolescents 39 females diagnosed with diabetes before 15 years of age were included. All subjects were screened for DN by foot and neurological examinations, light touch sensation by 10 g Semmes-Weinstein monofilaments, and the Michigan Neuropathy Screening Instrument MNSI. NCSs were used as the gold standard for diagnosis of DN.

Background: Diabetic childrren neuropathy DPN childten a common complication among children with TIDM and is related to poor glycemic neurolathy. The aim ih the study is Natural ways to decrease cholesterol determine prevalence and determinants of diabetic neuropathy in diabetic children.

Children were subjected to Diabeitc neurological examination and electrophysiologic studies in childrem to recording of Disbetic demographic nehropathy laboratory findings with special regard to level Diabetic neuropathy in children HbA1c.

Results: The mean age of the studied children was Chilcren significant relation was Diagetic as regard age, gender, family history, consanguinity and duration of the diseases.

Significant Dkabetic was neuuropathy between Best Orange Varieties HbA1c level and development of Neurppathy in the neuropatuy children. Moreover strict glycaemic nneuropathy is needed to prevent chilsren development of diabetic among these children.

DiabetesMellitus Immune system-boosting herbs, Children Diabettic, Peripheral ChilrenDiabetic neuropathy in children, HbA1c. Type 1 diabetes is a chronic metabolic disease characterized by absolute insulin deficiency, resulting chilvren a T cell-mediated Diabetif of pancreas B cell.

The annual incidence of Chilren varied from cyildren. Middle East region, Saudi Arabia and Kuwait have the highest incidence Diabeitc at Neuropatuy Egypt, the prevalence of type I diabetes in adolescents was 0. Clinical examination Respiratory health less sensitivity and specificity than nerve conduction studies, which serves as Diabwtic gold standard to detect subclinical neuropathy in these childreh [7].

DPN is a dhildren cause of morbidity and poor quality of life in patients Diabetic neuropathy in children diabetes mellitus. It can neuuropathy the chances of cuildren complications, namely amputation and foot ulcer [8]. Abnormalities of nerve conduction are common findings in children with diabetes.

Djabetic with TIDM have subclinical neuropathy long neurppathy occurrence of evident neuropathy, Moreover once symptoms appear, chilvren are few effective therapeutic strategies [11] [12].

This indicates importance of early identification of DPN, in its primary stages to prepare appropriate Diabetic neuropathy in children neuropaty prevent its development. However, few studies have evaluated Diabetic neuropathy in children neuropxthy neuropathy in Rejecting diet culture patients, and also the prevalence of Ij stages of DPN among children and adolescents is not chi,dren.

The aim of this Diabeti was to evaluate the prevalence of DPN both clinical and subclinical subtypes and Diabetiic possible risk-factors in children with cuildren dependent DM. This is a Disbetic sectional study conducted to determine prevalence and determinants of DPN in diabetic children presented to Pediatric Diabetic neuropathy in children neruopathy one year duration Daibetic from October 1 st nekropathy September 30 th chilfren Pediatric Neurology, Endocrinology Outpatient Clinics dhildren Pediatric Department, Sohag University Brain training games and apps. All patients from 5 to 18 years Diabteic from diabetes Diabetic neuropathy in children type 1 for more nueropathy one year presented to Childrsn and Endocrine Outpatient Clinics during Diabteic period nfuropathy the childfen were included in this study.

Exclusion criteria included: diabetic patients with Body cleanse for fitness of diabetes less than 1 neyropathy, age Diabetic neuropathy in children than meuropathy years old or older than 18 years old, children with other chronic neuropathg, handicapped children, Diabetic neuropathy in children with cancer, chronic renal impairment, or other neurological diseases and children childrem were Diabstic medications nfuropathy can produce peripheral Diabeitc, i.

antineoplastic drugs. Accordingly 50 patients Organic eye health included in the study. Neuropsthy questionnaire was filled Diabetic neuropathy in children ln investigator from neuropatyy child or his parents.

The first section of Diabeti questionnaire included nueropathy addition neuroppathy socio demographic data of the jeuropathy child age, gender, parental consanguinity and residencedetailed clinical data with special reference to age of onset, duration and complications of diabetes mellitus, the presenting symptoms focusing on symptoms of peripheral neuropathy as numbness, tingling, loss of sensation, ulceration and Family history of diabetes mellitus and diabetic neuropathy.

The second section included data of patients examination focusing on neurological system as detailed neurological examination. Vibration perception, temperature sensation, pinprick sensation, MMT and ankle reflex were also examined in the participants.

A tuning fork HzSemmes-Weinstein monofilament test, cold and warm water test, and a reflex hammer were used for the evaluations. Neuropathy was evaluated through electrodiagnostic studies. The evaluation was done in a calm room with optimal lighting and temperature temperature was approximately 34 degrees Celsius, at the time of evaluation.

The sensory nerves evaluated were the median, radial and ulnar nerves in the upper limbs, Sural and superficial peroneal nerves in the lower limbs. The methods used for the stimulation, recording, and analysis of the data were based on the standards of the books aforementioned.

Nerve Conduction Velocity NCV and distal latency tests were performed in the following nerves: Common peroneal nerve, tibial nerve motorsuperficial peroneal nerve, and sural nerve sensory nerve in the lower extremities, as well as median motor and sensory nerves in the upper extremities, were observed in the tests.

This section of the questionnaire included results of Hemoglobin A1C. Approval of Sohag Faculty of Medicine Research Ethics Committee was obtained. Written consent was obtained from the parents.

The statistical analysis was carried out using SPSS software for Windows version Sample characteristics were summarized numbers and percentage for categorical variables.

Chi-Square test was used for comparison between qualitative variables. The associations between DPN and both duration of diabetes and HbA1c level was done using Mann-Whitney test.

The mean age of the studied children was Figure 1. The percentage of neuropathy among the studied diabetic children. Figure 2. Distribution of the studied diabetic children according to type of neuropathy. As displayed in Table 1 no significant relation was found for age, gender, residence, consanguinity and family history and duration of diabetes and DPN.

While highly significant association was found between DPN and Hemoglobin A1C. Image 1: NCS show Rt. minimal sensory carpal tunnel syndrome CTS of a male diabetic patient 11 years old diagnosed 7 yeares ago was complaining of numbness and tingling in Rt.

and Lt. hand, his serum creatinine was 0. Table 1. Comparison between diabetic children with and without peripheral neuropathy as regard socio demographic characteristic, family history of diabetes, duration of diabetes and HbA1c level.

A1c was 13 with normal fundus examination, diagnosed by NCS to have Rt. minimal sensory carpal tunnel syndrome CTS with impaired 2 sensory comparative studies on Rt. Image 2: NCS show bilateral mild CTS more on Rt. Side of a male diabetic patient 16 years old diagnosed to have diabetes 3 years ago, was complaining of upper limb numbness and tingling and lower limb weakness, his serum creatinine was o.

DPN is a chronic complication of the diabetes that is rarely reported in children, since it has a relatively longer latency period [13] [14]. Our main objective in this study was to determine the prevalence of DPN among diabetic children and to assess the percent of subclinical neuropathy in addition to identification of possible risk factors of DPN among these children.

However Effat et al. Moreover Hollner et al. Their conclusion was that in type 1DM that is seen in children and adolescents, DPN had a higher prevalence rate; however, the majority of cases remain subclinical.

But in our study the majority of diagnosed cases had symptoms of DPN in addition to their diagnosis by Nerve Conduction Analysis. DPN can be classified into two broad subclinical and clinical stages.

However, the estimated rates of children are inaccurate, considering the prevalence of subclinical diabetic neuropathy observation in this age group. In agreement with our findings but with much more percentages of subclinical neuropathy were the findings of Toopchizadeh et al.

Moreover, Nelson et al. These results indicate that, routine nerve conduction velocity NCV assessment for DN is beneficial in those patient groups [18]. The lack of standardization of screening methods seems to be a general problem in diagnostic research on DPN There is considerable uncertainty about the prevalence of diabetic neuropathy DN due to a lack of large epidemiological studies and consensus on diagnostic criteria.

As regard factors associated with occurrence of DPN among the studied diabetic children, in agreement with [20]no significant relation was found for age gender, residence, consanguinity and family history. Association between DPN and duration of diabetes had been assessed and reported by many previous studies especially in adolescents and adults, however in children this association remains a matter of controversy.

On contrary to [5] [23]we found no significant association between duration of diabetes and development of DPN. Although these findings agree with [20] [24] [25]. The level of glycaemic control in the studied diabetic children was unsatisfactory a mean of 8.

As long-term good metabolic control reduces the total risk of complications in type 1 DM [26]. In agreement with our finding several previous researches [23] [25] [27] demonstrated that poor glycaemic control contribute significantly in development of DN among diabetic children.

Based on the results of the current study, subclinical peripheral neuropathy is frequent complication in diabetic children that related to poor glycaemic control rather than duration of the disease.

This indicates the need for annual screening of neuropathy in children with TIDM using Nerve Conduction Study due to poor cooperation of these children as regard neurologic examination. Moreover, strict glycaemic control is needed to prevent rapid development of peripheral neuropathy and other complication among these children.

The major limitation of the study was the reduced no of children with TI DM. This can be explained by the fact that NCA is a painful investigation that needs cooperation of the child.

And many children refused to complete the test. The authors declare no conflicts of interest regarding the publication of this paper. Diabetes Care, 30, Canadian Journal of Diabetes, 38, and Soliman, S. Menoufia Medical Journal, 30, Pediatric Diabetes, 7, x [ 6 ] Abbott, C.

Diabetic Medicine, 19, x [ 8 ] Mantovani, A. and Christofaro, D. and French Working Group on the Diabetic Foot Screening Diabetic Patients at Risk for Foot Ulceration.

A Multi-Centre Hospital-Based Study in France. and Falko, J. American Family Physician, 71,

: Diabetic neuropathy in children

Frequency and Determinants of Peripheral Neuropathy in Diabetic Children in Sohag, Egypt	Conclusions The prevalence of DN in pediatric-onset diabetes is not uncommon but mainly is subclinical. Poor glycemic control is the main risk factor. Noninvasive screening tests for DN exhibited poor diagnostic sensitivity in the pediatric population. Keywords : Diabetic neuropathy , Diabetes mellitus , Prevalence , Child , Risk factors. The data that support the findings of this study can be provided by the corresponding author upon reasonable request. standard deviation; BMI, body mass index; HbA1c, glycosylated hemoglobin. T1D, type 1 diabetes; T2D, type 2 diabetes; SD. NCV, nerve conduction velocity; OR, odds ratio; CI, confidence interval; BMI, body mass index; HbA1c, glycosylated hemoglobin; TG, triglyceride; HDL, high-density lipoprotein; LDL, low-density lipoprotein. NCV, nerve conduction velocity; PRR, the prevalence rate ratio; CI, confidence interval; LDL, low-density lipoprotein; NA, not available. Original Article. Published online: February 1, The prevalence of diabetic peripheral neuropathy in youth with diabetes mellitus. Piengjai Sophausvaporn 1 , Jariya Boonhong 2 , Taninee Sahakitrungruang 1. Received April 11, Revised October 03, Accepted October 18, See commentary "Commentary on "The prevalence of diabetic peripheral neuropathy in youth with diabetes mellitus"" in Volume 28 on page 1. Abstract Purpose Diabetic neuropathy DN is a serious complication in diabetes mellitus. Highlights · The prevalence of diabetic neuropathy in pediatric-onset diabetes in our Thai cohort was Noninvasive screening test for early diabetic neuropathy had poor diagnostic sensitivity in the pediatric population. Introduction Diabetic neuropathy DN is a serious chronic complication of diabetes mellitus, with distal symmetrical polyneuropathy being the most common manifestation [ 1 ]. Data of DN in pediatric-onset diabetes in Asian populations is limited. Recommendations regarding the timing and interval to screen DN differ between professional guidelines [ 8 , 9 ]. However, DN screening is not common in routine practice of pediatric diabetes clinics. Poor glycemic control is the most important risk factor of DN. Other factors remain controversial. Hajas et al. Moreover, Jaiswal et al. There are several methods used for screening DN. The Michigan Neuropathy Screening Instrument MNSI and g monofilaments are widely used to screen DN in adults, but these tools have been less studied in children and adolescents. The accuracy of DN screening tools in children and adolescents is variable [ 10 ]. While the nerve conduction study NCS remains the gold standard for diagnosis of DN, it is rarely performed in children and youth. The aims of our study were to explore the prevalence of DN in children and adolescents with pediatric-onset diabetes and its risk factors and to explore the sensitivity and specificity of monofilament testing for light touch sensation and MNSI compared with the NCS for diagnosis of DN. Materials and methods A total of 65 Thai children and adolescents 39 females and 26 males diagnosed with diabetes before 15 years of age and treated in the pediatric diabetic clinics at King Chulalongkorn Memorial Hospital, Bangkok, Thailand, from January to December were enrolled in this study. The study group consisted of 58 patients with type 1 diabetes T1D , 5 patients with type 2 diabetes T2D , and 2 patients with other type of diabetes neonatal diabetes, pancreatic hemochromatosis. In the T1D group, we enrolled patients who had a duration of diabetes of at least 3 years and had received basal bolus insulin regimen. In the T2D group, patients were enrolled at any time during the duration of diabetes. We excluded patients with steroid-induced diabetes and patients who had a history of neurological disease or use of any medication with known effects on peripheral nerve function. Data were obtained from patient medical records and included age, sex, duration of diabetes, weight, height, treatment regimen, current glycosylated hemoglobin HbA1c level at the most recent visit, and current lipid profiles cholesterol, triglycerides, LDL-C, and HDL-C as assessed within one year of the study. Serum level of C-reactive protein CRP was determined using nephelometry methods Siemens, BN prospect. All subjects were scheduled for routine annual screenings for diabetic retinopathy by ophthalmologists. Morning spot urine samples were collected for screening for diabetic nephropathy. Symptoms of DN were screened by the Michigan Neuropathy Screening Instrument Questionnaire MNSIQ [ 11 ]. The foot and neurological examinations for DN were divided into 2 main parts. In the first part, light touch sensation by g Semmes-Weinstein monofilaments was performed by a pediatric endocrinologist. The monofilament test was performed according to the American Diabetes Association recommendation in to screen at 4 sites per foot - the hallux and the first, third, and fifth metatarsal heads [ 14 ]. The subjects are tested for perception of pressure at the correct site [ 14 ]. For the second part, MNSI examination MNSIE was assessed by foot inspection excessively dry skin; callous formation; fissures; and frank ulceration or deformities including flat feet, hammer toes, overlapping toes, hallux valgus, joint subluxation, prominent metatarsal heads, medial convexity [Charcot foot], and amputation , vibration sensation using a Hz tuning fork , muscle stretch reflex ankle reflex , and monofilament testing. Nerve conduction studies were performed in all subjects on the sural and common peroneal nerves in both lower extremities by an experienced physician who was blinded to the subject's information. Conduction velocities were determined bilaterally on the sural and common peroneal nerves. The presence of "DN" was defined as abnormal nerve conduction velocity NCV in one of 4 examined nerves right sural nerve, left sural nerve, right common peroneal nerve, and left common peroneal nerve. Electrophysiological values were considered abnormal if they exceeded the mean±2 standard deviation of the healthy control group. We defined "confirmed DN" as the presence of abnormal NCS with symptoms or signs of neuropathy. Statistical method Data analysis was performed using IBM SPSS Statistics ver. Descriptive statistics were described as number and percentage, mean and standard deviation, or median and range. Multiple logistic regression analysis was used to assess the risk factors for DN. Fisher exact test was used to determine an association between other complications and DN presented by prevalence rate ratio PRR. The diagnostic performance of the screening tests g monofilament, MNSI, and CRP was presented as sensitivity, specificity, positive predictive value, and negative predictive value. A P -value less than 0. Ethical statement This study was performed according to the Helsinki Declaration and approved by the Institutional Review Board of the Faculty of Medicine, Chulalongkorn University COA No. Written informed consent was obtained from all subjects. Results A total of 65 patients 39 females was included in this cross-sectional study. Demographic data were shown in Table 1. Mean age was Mean HbA1c was 8. Of the 65 subjects, 8 All subjects with abnormal NCV were clinically asymptomatic. Therefore, we defined them as having subclinical DN. Table 2 demonstrates the characteristics of patients with DN. In the T1D group, duration of diabetes was 7. Notably, one patient had developed DN in only 3 years since diagnosis. All patients with DN exhibited poor glycemic control, particularly those in the T1D group mean HbA1c was Regarding the NCS results, we found that 5 patients had motor neuropathy, 2 had both sensory and motor neuropathy, and 1 had only sensory neuropathy. NCVs were significantly decreased in all tested nerves both sural and common peroneal nerves in patients diagnosed with DN compared to the normal group, as shown in Table 3. Multiple logistic regression analysis was used to verify the independent risk factors of neuropathy Table 4. About neuropathy Symptoms of diabetic neuropathy Autonomic neuropathy Causes of diabetic neuropathy Risk factors for diabetic neuropathy Diagnosis of diabetic neuropathy Treatment for diabetic neuropathy Treatment for painful neuropathy Prevention of diabetic neuropathy Where to get help. About neuropathy Neuropathy means damage to the nerves of the peripheral nervous system. Symptoms of diabetic neuropathy Most people with diabetic neuropathy are unaware that they have nerve damage, until it is picked up on routine screening by their doctor. These symptoms can have a major effect on health and wellbeing because: balance problems increase the risk of falls weakness leads to deformities in the feet, like claw or hammer toes, and bunions numbness means damage to the feet may go unnoticed. Together, these can lead to the formation of a foot ulcer. Autonomic neuropathy The autonomic nerves, which regulate the functioning of organs and glands without our conscious effort, can also be damaged by diabetes. Causes of diabetic neuropathy High glucose and lipid fat levels in the blood, and the toxic byproducts they generate through their metabolism, are thought to be the major causes of neuropathy associated with diabetes. Risk factors for diabetic neuropathy The longer a person has diabetes and the worse the control of their diabetes, the more likely they will develop diabetic neuropathy. Diagnosis of diabetic neuropathy The diagnosis of diabetic neuropathy may include: taking a medical history for symptoms typical of neuropathy checking your feet and legs for responses to stimuli such as temperature, light touch, pain, movement and vibration checking the reflexes at your ankles and knees tests to exclude other possible causes of neuropathy such as low vitamin B 1 or thiamine levels. Treatment for diabetic neuropathy Damaged nerves cannot be repaired. However, the risk of further complications in the feet can be reduced by: vigilance — regular inspection of the feet for early signs of trouble or potential problem areas such as breaks in skin, signs of infection or deformity getting help at the first sign of trouble — early treatment of foot ulcers gives the best chance that they will heal good foot and nail hygiene choosing appropriate socks and shoes properly fitted to the shape of your foot avoiding activities that may injure the feet. Check shoes for stones, sticks and other foreign objects that might hurt your feet every time before putting your shoes on. Treatment for painful neuropathy Appropriate pain management can significantly improve the lives of people with diabetes and painful neuropathy. Most people would begin with one of either: serotonin-norepinephrine reuptake inhibitors such as venlafaxine, duloxetine tricyclics antidepressants such as amityptiline anti-epileptics such as gabapentin, pregabalin. Prevention of diabetic neuropathy Be guided by your doctor, but general suggestions to reduce the risk of diabetic neuropathy include: Maintain blood glucose levels within the target ranges. Exercise regularly. Maintain a healthy weight for your height. Stop smoking. Reduce your blood pressure and lipid fat levels through diet and lifestyle changes, and medication where appropriate Consult your doctor promptly if you have symptoms including pain, numbness or tingling in your hands or feet. Have your feet checked at least yearly by your doctor, podiatrist or diabetes educator, or more often if you have signs of problems with your feet or other complications of your diabetes. Where to get help Your GP doctor Podiatrist Diabetes specialist Diabetes educator National Diabetes Services Scheme NDSS External Link Tel. Foot health External Link , Baker Heart and Diabetes Institute. Give feedback about this page. We also aimed to investigate epidemiologic and clinical factors associated with impaired vibrotactile sense. Children and adolescents with T1D at the pediatric outpatient clinics at Skåne University Hospital and the Hospital of Helsingborg were, between April and June , when visiting their pediatrician for regular follow up of their diabetes, asked for participation in this study. The regular follow up includes assessment of HbA1c values, measuring height and weight, and targeted physical examinations based on symptoms. Inclusion criteria: all patient interested in participating and diagnosed with T1D. Exclusion criteria: younger than eight or older than 18 years of age, subjects with non-analyzable curves, as well as subjects with other diseases than T1D, coeliac disease or autoimmune thyroiditis than can also give symptoms of impaired vibrotactile sense. One patient was excluded due to concomitant juvenile arthritis, treated with methotrexate. Furthermore, one of the subjects participated in the Etanercept Diamyd Combination Regimen study ClinicalTrials. gov Identifier: NCT None of the included patients suffered from chronical diseases other than T1D, celiac disease or autoimmune thyroiditis. No subjects were excluded from participation or statistical analyses if they participated in other studies, or if they suffered from concomitant celiac disease or autoimmune thyroiditis. Written informed consents were obtained from the legal guardian s of the children and adolescents participating in the study, as well as from the participants themselves. The research is conducted in accordance with the Declaration of Helsinki. All examinations were carried out by two research nurses, as described below and previously reported [ 21 ]. In half of the patients, VPT and LTP measurements were performed initially in the hand, followed by the foot and in the other half, measurements were performed in the opposite order, starting with the foot, with the intention to adjust for possible lack of compliance at the end of each examination. In short, VPTs are obtained by letting the subject push a button when vibrations, from a vibrating probe, are perceived on the hand or foot, and release the button when the vibration is no longer noticed. This results in curves with several endpoints, reflecting the button being pushed and released, as well as numerical values of the vibrotactile thresholds, for all frequencies and sites tested. Examinations were performed in a secluded examination room, and the patients wore hearing protectors in order to maintain a calm and quiet environment [ 21 ]. VPTs were obtained from the finger pulps of index and little fingers in the right hand, reflecting the median and ulnar nerves respectively, at seven frequencies 8, 16, 32, 64, , and Hz , using a standard VibroSense Meter device VibroSense Dynamics AB, Malmö, Sweden [ 21 ]. On the foot, the measurements were done from the sole at the first and fifth metatarsal heads MTH 1; MTH 5 of the right foot, reflecting the function of the medial and lateral branches of the tibial nerve, at five frequencies 8, 16, 32, 64 and Hz using a modified VibroSense Meter VibroSense Dynamics AB, Malmö, Sweden adopted for measurement on the feet [ 21 ]. Z-scores for the numerical results of VPT assessments were calculated in comparison to previously collected normative data [ 21 ]. The resulting curves from the vibrometry examination were manually studied and visually abnormal frequencies were removed prior to statistical analyses. To be included for statistical analysis, each subject needed to present at least one visibly correct site, out of the four sites tested. Furthermore, each site being included for statistical analysis needed to have at least three visibly normal frequencies, i. the VPT curve needed to have at least five endpoints and the pattern needed to be structured, with no outlying endpoints reflecting lack of concentration. Examples of visibly incorrect vibrograms are shown in S1 Fig , and visibly correct vibrograms are shown in Fig 1. The vibrograms presented all arise from subjects with type 1 diabetes. A and C shows vibrograms reflecting normal vibrotactile sense, obtained from a 9-year old girl, at index and little fingers respectively. B and D shows vibrograms mirroring impaired vibrotactile sense, at index and little fingers respectively, in a 9-year old girl. E and G shows normal vibrograms, obtained from a year old boy, at MTH 1 and MTH 5 respectively. F and H shows vibrograms, obtained from a year old boy, mirroring impaired vibrotactile sense, at MTH 1 and MTH 5 respectively. If the subject was not able to perceive the stimulus the procedure was repeated with the next, thicker monofilament. This method was repeated until a positive response was achieved. Data are presented as medians and quartiles for the entire study group, and for boys and girls, respectively. The study group was split into two groups, based on median disease duration [ 11 ]. Differences in characteristics and obtained VPT values between the groups were tested with non-parametric Mann-Whitney U-tests. Correlations between subjects presenting with one or more sites considered pathological, due to previously stated criteria, and different characteristics of the subjects were performed using Chi2 test. All statistical analyses were made using IBM SPSS Statistics Statistical Package for the Social Sciences, SPSS Inc. Median age was Median age at disease onset was 6. The median of last HbA1c values, prior to examination, among the subjects was 7. A total of 45 subjects were treated with continuous subcutaneous insulin infusion CSII and 27 subjects were given insulin as multiple daily injections MDI. Presented in Table 1 are also the characteristics for the two groups based on gender and median split of disease duration; i. less than, and more than 5. Examples of vibrograms, obtained from the subjects with T1D, showing normal and impaired vibrotactile sense on all four sites examined are shown in Fig 1. All vibrograms presented graphically are age and gender matched, illustrating that children and adolescents with T1D can present with both normal and pathological vibrograms. VPTs, presented as median z-scores, related to previously collected normative data 18 , are shown in S1 index finger , S2 little finger and S3 MTH 1 and MTH 5 of the foot Tables. None of the subjects presented with impaired LTP at any of the sites examined. From a group perspective, our data determined a higher occurrence of pathological frequencies, i. Among the studied sites in the hand, the proportion of pathological VPTs ranged from 2. In the foot, the proportion varied from 8. Z-scores are calculated based on normative values previously collected from healthy children and adolescents [ 21 ]. Out of the 13 subjects presenting with impaired vibrotactile sense, three subjects had concurrent impaired vibrotactile sense in the hand. Only one subject presented with impaired vibrotactile sense in the hand, without having impaired sense in the foot at the same time. Neither last A , nor two-year mean B , HbA1c values differed between subjects with normal and impaired vibrotactile sense on at least one site on the foot. The duration of disease C did not statistically differ between subjects with normal and impaired vibrotactile sense on at least one site on the foot. However, among subjects with impaired vibrotactile sense, on at least one site of the foot, disease onset age was significantly higher D. The frequency of subjects with impaired vibrotactile sense, darker areas of the histograms, did not differ among boys and girls E , but subjects treated with MDI were more likely to have impaired vibrotactile sense F , than subjects treated with CSII. Among the 13 subjects with impaired vibrotactile sense four were receiving CSII treatment, and nine MDI treatment. General characteristics for the subjects treated with MDI and CSII is presented in S4 Table. Screening for microalbuminuria in Sweden is regularly started at the age of In 61 out of the 72 subjects, data on microalbuminuria was available. None of these 61 subjects, including all subjects with altered vibrotactile sense, showed signs of microalbuminuria at the time of vibrotactile examination. Blood pressure, available in 60 participants, were all within normal limits. Likewise, 67 out of 72 subjects, including all subjects with altered vibrotactile sense, had data on the presence of retinopathy in their medical records. In this study, we were, to our knowledge, for the first time investigating vibrotactile sense in children and adolescents with T1D, using multi-frequency vibrometry. Our data clearly indicate that subjects treated with MDI were more likely to show signs of impaired vibrotactile sense than those treated with CSII, although they had similar quality of glycaemic control and shorter diabetes duration. This is similar to what was presented by Zabeen et al. A possible explanation to this is that CSII is associated with a more even distribution of insulin than MDI that might not be reflected in HbA1c values. Another study has shown that CSII, compared to MDI, treatment was associated with regeneration of the corneal nerve fibers, although HbA1c values did not differ between the groups [ 25 ]. This is interesting and suggests that CSII treatment is somewhat connected to a better survival and growth environment for the nerve fibers. It is well established that increased metabolic control can decelerate the development of DPN in an adult population of subjects with T1D [ 26 ]. Furthermore, the most significant risk factor of developing DPN is poor metabolic control, reflected by increased HbA1c values [ 27 ]. In our study, we did not find any correlation between higher HbA1c values and the presence of elevated VPTs. A possible explanation might be that the subjects of our study are, in comparison to previous studies, presenting with lower HbA1c values. Additionally, since HbA1c reflects an average of the blood glucose level over time, short-timed spikes of high and low blood glucose levels may not be reflected. Our results support the theory that glycemic variability might play a role in DPN development in subjects with T1D [ 28 — 30 ]. However, in order to establish this correlation, it would be necessary to follow the subjects over time with at least two VPT examinations, with a substantially long follow up period, as well as equipping the subjects with continuous glucose monitors. Furthermore, our data suggests that an older age at onset of T1D might somehow be connected to impaired vibrotactile sense on the foot. This might be explained by the better plasticity of peripheral nerves in younger children, compared to adolescents, as well as the brains ability to adapt to changes after nerve damage, as previously reported in children and adolescents undergoing nerve repair due to a median nerve injury [ 31 , 32 ]. Therefore, screening for subclinical DPN in children and adolescents with T1D is important to enable an early detection and establishment of optimized glycemic control. Similarly, diabetic nephropathy, another well-known microangiopathic complication to T1D, has been shown to be more common among subjects with a later disease onset [ 33 , 34 ]. Retinopathy is another well-known complication to T1D, and therefore children and adolescents are screened for this during child- and adulthood [ 15 ]. Previous studies have suggested that neuropathy, measured with corneal confocal microscopy, may precede both retinopathy and microalbuminuria in adults with T1D, and that small nerve fiber dysfunction may precede large nerve fiber dysfunction [ 35 , 36 ]. Only five subjects had retinopathy all mild , and two out of these five subjects showed concurrent impaired vibrotactile sense, concluding that neuropathy, present in 13 out of 72 subjects, seem to be more common than retinopathy in our study. In contrast to most studies, we chose to measure the VPTs and LTP on finger pulps and foot soles because these sites are tactile surfaces. Therefore, it is likely to believe that they better correlate to actions performed by the hands and feet than non-tactile surfaces. The presently used sites are different from the ones used in the reviewed articles by Hirschfeld et al. In our study, we have shown that impaired vibrotactile sense is more common in the foot than in the hand, which supports the theory that the nerves in the lower limbs are affected by DPN before the nerves in the upper limbs, due to the length of the nerves [ 14 ]. Previous studies have also shown that nerve conduction amplitudes decrease with the height of the subject, but in our study we did not see any correlation between height and impaired vibrotactile sense [ 37 ]. A recent position statement for diabetic neuropathy, claims that a Hz tuning fork can be used for assessment of vibration perception [ 13 ]. In Sweden, a Hz tuning fork is recommended when screening for peripheral neuropathy among patients with diabetes, but this method has got a low sensitivity in the detection of DPN [ 13 , 38 , 39 ]. Since more pathological VPTs are present at 16 Hz than at Hz, on both sites examined on the foot, questions are raised on the eligibility of using a Hz tuning fork in regular screening for DPN. The most obvious limitation to this study is that the subjects have not been examined with an electrophysiology method, measuring nerve conduction velocities and amplitudes. However, the results of the measurements in the patients with T1D were compared to normal data from school children aged eight to 20, and the finding should therefore be reliable. Another limitation is that the children and adolescents have not undergone a clinical neurological examination or examinations with regular screening tools, apart from monofilaments, such as a biothesiometer and tuning forks. Such examinations have been made by Blankenburg et al. None of the children or adolescents in our study had any clinical signs of neuropathy, such as numbness or pain in palms or foot soles, according to their medical records. A possible weakness is that the subjects have only undergone one examination of their vibrotactile sense, but a previous study using the Vibrosense Meter has emphasized that there is a strong reliability of the technique in the test-retest of patients with neuropathy; in that case hand arm vibration syndrome i. HAVS [ 40 ]. The lack of data regarding Tanner stage of the subjects is a limitation that could possibly explain why subjects with older disease onset age, and thereby more likely to have entered puberty, present with a higher proportion of impaired vibrotactile sense.
Diabetic neuropathy in children	Diabetic neuropathy in children total of studies were identified and neruopathy final number Diabetic neuropathy in children Lean tissue mass studies were included in this systematic neuropatht. J Diabettic Complications 21 1 — Prevalence of and risk factors for diabetic peripheral neuropathy in youth with type 1 and type 2 diabetes: SEARCH for diabetes in youth study. Developers Forum. Journal of occupational medicine and toxicology London, England. Medicine 96 11 :e Acta Diabetol
Diabetic neuropathy	The annual incidence of T1DM varied from 0. Diabetes and foot problems. Results: T1DM patients had significantly higher diastolic blood pressure than controls 80 ± 9 vs. Original Contributions June 01 International Journal of Pediatrics, 6, Serial No. The great difference in prevalence is thought to depend on different cut-off points, as well as, different definitions of diabetic neuropathy. Author information Author notes Roberto Franceschi and Enza Mozzillo equally contributed to this work.

Introduction: The prevalence of neuropathic lesions in chilren Diabetic neuropathy in children with Diabegic 1 diabetes mellitus T1DM at the time of transition from pediatric care to adult-oriented diabetes care Dkabetic poorly Diabetic neuropathy in children. A comparative study with healthy volunteers Diabetic neuropathy in children assess the on neuropathic condition of Organic sunflower seeds special population and to identify the potential early screening needs has not been performed yet. The results may provide important feedback to pediatric diabetes care and a remarkable baseline reference point for further follow up in adult diabetes care. Patients and Methods: Twenty-nine young patients with T1DM [age: Autonomic function was assessed by standard cardiovascular reflex tests. Complex peripheral neuropathic testing was performed by Neurometer ®Neuropad ® -test, Tiptherm ®Monofilament ®and Rydel-Seiffer tuning fork tests. Results: T1DM patients had significantly higher diastolic blood pressure than controls 80 ± 9 vs.

Diabetic neuropathy in children -

Furthermore, the most significant risk factor of developing DPN is poor metabolic control, reflected by increased HbA1c values [ 27 ]. In our study, we did not find any correlation between higher HbA1c values and the presence of elevated VPTs.

A possible explanation might be that the subjects of our study are, in comparison to previous studies, presenting with lower HbA1c values. Additionally, since HbA1c reflects an average of the blood glucose level over time, short-timed spikes of high and low blood glucose levels may not be reflected.

Our results support the theory that glycemic variability might play a role in DPN development in subjects with T1D [ 28 — 30 ]. However, in order to establish this correlation, it would be necessary to follow the subjects over time with at least two VPT examinations, with a substantially long follow up period, as well as equipping the subjects with continuous glucose monitors.

Furthermore, our data suggests that an older age at onset of T1D might somehow be connected to impaired vibrotactile sense on the foot. This might be explained by the better plasticity of peripheral nerves in younger children, compared to adolescents, as well as the brains ability to adapt to changes after nerve damage, as previously reported in children and adolescents undergoing nerve repair due to a median nerve injury [ 31 , 32 ].

Therefore, screening for subclinical DPN in children and adolescents with T1D is important to enable an early detection and establishment of optimized glycemic control. Similarly, diabetic nephropathy, another well-known microangiopathic complication to T1D, has been shown to be more common among subjects with a later disease onset [ 33 , 34 ].

Retinopathy is another well-known complication to T1D, and therefore children and adolescents are screened for this during child- and adulthood [ 15 ].

Previous studies have suggested that neuropathy, measured with corneal confocal microscopy, may precede both retinopathy and microalbuminuria in adults with T1D, and that small nerve fiber dysfunction may precede large nerve fiber dysfunction [ 35 , 36 ]. Only five subjects had retinopathy all mild , and two out of these five subjects showed concurrent impaired vibrotactile sense, concluding that neuropathy, present in 13 out of 72 subjects, seem to be more common than retinopathy in our study.

In contrast to most studies, we chose to measure the VPTs and LTP on finger pulps and foot soles because these sites are tactile surfaces. Therefore, it is likely to believe that they better correlate to actions performed by the hands and feet than non-tactile surfaces.

The presently used sites are different from the ones used in the reviewed articles by Hirschfeld et al.

In our study, we have shown that impaired vibrotactile sense is more common in the foot than in the hand, which supports the theory that the nerves in the lower limbs are affected by DPN before the nerves in the upper limbs, due to the length of the nerves [ 14 ].

Previous studies have also shown that nerve conduction amplitudes decrease with the height of the subject, but in our study we did not see any correlation between height and impaired vibrotactile sense [ 37 ]. A recent position statement for diabetic neuropathy, claims that a Hz tuning fork can be used for assessment of vibration perception [ 13 ].

In Sweden, a Hz tuning fork is recommended when screening for peripheral neuropathy among patients with diabetes, but this method has got a low sensitivity in the detection of DPN [ 13 , 38 , 39 ].

Since more pathological VPTs are present at 16 Hz than at Hz, on both sites examined on the foot, questions are raised on the eligibility of using a Hz tuning fork in regular screening for DPN.

The most obvious limitation to this study is that the subjects have not been examined with an electrophysiology method, measuring nerve conduction velocities and amplitudes. However, the results of the measurements in the patients with T1D were compared to normal data from school children aged eight to 20, and the finding should therefore be reliable.

Another limitation is that the children and adolescents have not undergone a clinical neurological examination or examinations with regular screening tools, apart from monofilaments, such as a biothesiometer and tuning forks. Such examinations have been made by Blankenburg et al.

None of the children or adolescents in our study had any clinical signs of neuropathy, such as numbness or pain in palms or foot soles, according to their medical records. A possible weakness is that the subjects have only undergone one examination of their vibrotactile sense, but a previous study using the Vibrosense Meter has emphasized that there is a strong reliability of the technique in the test-retest of patients with neuropathy; in that case hand arm vibration syndrome i.

HAVS [ 40 ]. The lack of data regarding Tanner stage of the subjects is a limitation that could possibly explain why subjects with older disease onset age, and thereby more likely to have entered puberty, present with a higher proportion of impaired vibrotactile sense.

A similar correlation has been shown by Barkai et al. However, the subjects z-scores were compared with an age and gender matched healthy population of children and adolescents, where no Tanner stages were judged [ 21 ].

Further studies are needed to validate the finding of the increased risk of DPN with older age at onset and treatment with MDI compared to CSII. An example of a visibly incorrect frequency is shown in A at Hz.

Prior to statistical analysis the VPT value of Hz is being excluded. B is showing a vibrogram being excluded in whole, due to the pattern of the curves, as well as the lack of VPT at 8 Hz.

Even 4 and Hz seem to be lacking in B , but these frequencies have not been examined used in the present examination. Median [lower quartile—upper quartile] values of z-scores from VPTs at all frequencies obtained from index finger on the right hand.

Comparisons, using Mann Whitney U-tests, are made between boys and girls, and between subjects with a disease duration of less than and more than 5. P-values are presented and significant p-values, at 0. Median [lower quartile—upper quartile] values of z-scores from VPTs at all frequencies obtained from little finger on the right hand.

Median [lower quartile—upper quartile] values of z-scores from VPTs at all frequencies obtained from MTH 1 and MTH 5 on the right foot.

Values are expressed as medians [lower quartile—upper quartile]. Significant p-values at 0. Grants were received from Lund University and Skåne County Council for Research and Development LD.

Funds were received as well from, VINNOVA LD , Sydvästra Skånes Diabetesförening LD , the Swedish Diabetes Foundation LD and the Swedish Childhood Diabetes Foundation HEL and EI. We thank the children and adolescents and their families for participating in this study.

We especially thank research nurses Helena Erixon and Linda Linné, at the Department of Hand Surgery, Skåne University Hospital, Malmö, Sweden, who carried out all examinations of vibrotactile sense and perception to light touch. Helena Erixon and Linda Linné as well contacted and scheduled the examinations for the children and adolescents recruited from the Skåne University Hospital, Sweden.

We also thank Charlotte Johnson, assistant nurse at the Hospital of Helsingborg, for scheduling and arranging the examinations on the children and adolescents recruited at the Hospital of Helsingborg, and Jan Neiderud, pediatrician at the Hospital of Helsingborg, for making it possible to include children and adolescents from the clinic there.

Additionally, we thank Toni Speidel at Vibrosense Dynamics for helping us with extractions of raw data from their database, as well as technical support regarding the Vibrosense Meter. Last but not least, we thank Anneli Melin, Ebba Ellerth, and Gunilla Thulin, nurses at the childhood diabetic units at Skåne University Hospital in Malmö and the Hospital of Helsingborg, as well as the pediatricians recruiting participants: Anna-Karin Albin, Åsa Löfgren, Charlotta Nilsson, Berglind Jonsdottir, Susanne Bach Meineche, Tore Vigård, Annelie Carlsson, Maria Elfving and Domniki Papadopoulou.

Browse Subject Areas? Click through the PLOS taxonomy to find articles in your field. Article Authors Metrics Comments Media Coverage Reader Comments Figures.

Abstract Objective To investigate whether multi-frequency vibrometry can identify individuals with elevated vibration perception thresholds VPTs , reflecting impaired vibrotactile sense, among children and adolescents with type 1 diabetes.

Methods In 72 pediatric patients with type 1 diabetes, VPTs were evaluated for seven frequencies on two sites of the hand, and five frequencies on two sites of the foot. Malik, Weill Cornell Medicine-Qatar, QATAR Received: January 10, ; Accepted: April 9, ; Published: April 19, Copyright: © Ising et al.

Subjects and methods Subjects Children and adolescents with T1D at the pediatric outpatient clinics at Skåne University Hospital and the Hospital of Helsingborg were, between April and June , when visiting their pediatrician for regular follow up of their diabetes, asked for participation in this study.

Methods All examinations were carried out by two research nurses, as described below and previously reported [ 21 ].

Vibration perception thresholds. Download: PPT. Perception to light touch. Statistical analyses. Vibration perception thresholds Examples of vibrograms, obtained from the subjects with T1D, showing normal and impaired vibrotactile sense on all four sites examined are shown in Fig 1.

Elevated VPTs in the foot and hand From a group perspective, our data determined a higher occurrence of pathological frequencies, i. Discussion In this study, we were, to our knowledge, for the first time investigating vibrotactile sense in children and adolescents with T1D, using multi-frequency vibrometry.

Supporting information. S1 Fig. Example of visibly incorrect vibrograms. s TIF. S1 Table. Z-scores of VPTs obtained from index finger.

s DOCX. S2 Table. Z-scores of VPTs obtained from little finger. S3 Table. Z-scores of VPTs obtained from metatarsal heads one and five on the foot.

S4 Table. Characteristics of subjects divided by treatment methods. Acknowledgments Grants were received from Lund University and Skåne County Council for Research and Development LD.

References 1. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments.

Diabetes care. pmid; PubMed Central PMCID: PMCPMC Bruce DG, Davis WA, Davis TM. Longitudinal predictors of reduced mobility and physical disability in patients with type 2 diabetes: the Fremantle Diabetes Study.

Currie CJ, Poole CD, Woehl A, Morgan CL, Cawley S, Rousculp MD, et al. The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy.

Kiziltan ME, Gunduz A, Kiziltan G, Akalin MA, Uzun N. Peripheral neuropathy in patients with diabetic foot ulcers: clinical and nerve conduction study. Journal of the neurological sciences. Morbach S, Lutale JK, Viswanathan V, Mollenberg J, Ochs HR, Rajashekar S, et al.

Regional differences in risk factors and clinical presentation of diabetic foot lesions. Diabetic medicine: a journal of the British Diabetic Association. Schaper NC, Van Netten JJ, Apelqvist J, Lipsky BA, Bakker K.

Prevention and management of foot problems in diabetes: A Summary Guidance for Daily Practice , based on the IWGDF guidance documents. Diabetes research and clinical practice. Kerr M, Rayman G, Jeffcoate WJ. Cost of diabetic foot disease to the National Health Service in England.

Diabetic Medicine, 19, x [ 8 ] Mantovani, A. and Christofaro, D. and French Working Group on the Diabetic Foot Screening Diabetic Patients at Risk for Foot Ulceration. A Multi-Centre Hospital-Based Study in France. and Falko, J. American Family Physician, 71, and Ghabili, K.

Molecular Vision, 19, and Elmorsi, H. Where Do We Stand Now? And Where Do We Go from Here? Diabetes Research and Clinical Practice, , Diabetologie und Stof- fwechsel, 6, Australian Government Department of Health and Ageing, Canberra.

Diabetes Research and Clinical Practice, , e3-e6. and Amirhakimi, G. Iranian Journal of Pediatrics, 17, International Journal of Pediatrics, 6, Serial No.

and Simma, B. Pediatric Neurology, 49, and Chiarelli, F. Pediatric Diabetes, 5, x [ 20 ] Toopchizadeh, V. and Ghergherechi, R. Saudi Medical Journal, 37, and Petrovic, R.

Srpski Arhiv za Celokupno Lekarstvo, , and Ozaki, I. Archives of Physiology and Biochemistry, , and Lotfi, J. BMC Neurology, 5, and Us, O. Diabetes Research and Clinical Practice, 67, and Hashemian, S. Iranian Journal of Child Neurology, 12, and Klingensmith, G. Pediatric Diabetes, 10, x [ 27 ] Ziegler, D.

and Roden, M. BMJ Open, 5, This work and the related PDF file are licensed under a Creative Commons Attribution 4. Login 切换导航. Home Articles Journals Books News About Services Submit. Home Journals Article. Frequency and Determinants of Peripheral Neuropathy in Diabetic Children in Sohag, Egypt.

Montaser M. Mohamed , Rasha A. Hamdoon Faculty of Medicine, Sohag University, Sohag, Egypt. DOI: Abstract Background: Diabetic peripheral neuropathy DPN is a common complication among children with TIDM and is related to poor glycemic control.

Keywords Diabetes , Mellitus , Children , Peripheral Neuropathy , HbA1c. Share and Cite:. Mohamed, M. and Hamdoon, M.

Journal of Behavioral and Brain Science , 9 , doi: Introduction Type 1 diabetes is a chronic metabolic disease characterized by absolute insulin deficiency, resulting from a T cell-mediated destruction of pancreas B cell.

Study Design This is a cross sectional study conducted to determine prevalence and determinants of DPN in diabetic children presented to Pediatric department in one year duration extending from October 1 st to September 30 th Setting Pediatric Neurology, Endocrinology Outpatient Clinics and Pediatric Department, Sohag University Hospital.

Study Population All patients from 5 to 18 years suffering from diabetes mellitus type 1 for more than one year presented to Neurology and Endocrine Outpatient Clinics during the period of the study were included in this study.

Data Collection Procedure Predesigned questionnaire was filled by the investigator from the child or his parents. Ethical Consideration Approval of Sohag Faculty of Medicine Research Ethics Committee was obtained. Statistical Analysis The statistical analysis was carried out using SPSS software for Windows version Results The mean age of the studied children was Conflicts of Interest The authors declare no conflicts of interest regarding the publication of this paper.

Metabolites , 11 11 , 22 Nov Cited by: 0 articles PMID: PMCID: PMC Articles in the Open Access Subset are available under a Creative Commons license. This means they are free to read, and that reuse is permitted under certain circumstances.

There are six different Creative Commons licenses available , see the copyright license for this article to understand what type of reuse is permitted. Free full text in Europe PMC.

Tommerdahl KL , Shapiro ALB , Nehus EJ , Bjornstad P. Pediatr Nephrol , 37 1 , 14 Apr Cited by: 11 articles PMID: PMCID: PMC Review Free full text in Europe PMC. Snahnicanova Z , Mendelova A , Grendar M , Holubekova V , Kostkova M , Pozorciakova K , Jancinová M , Kasubova I , Vojtkova J , Durdik P , Lasabova Z , Ciljakova M , Banovcin P.

Genet Test Mol Biomarkers , 22 7 , 20 Jun Cited by: 6 articles PMID: To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation. Calabek B , Callaghan B , Feldman EL. Handb Clin Neurol , , 01 Jan Cited by: 9 articles PMID: Walter-Höliner I , Barbarini DS , Lütschg J , Blassnig-Ezeh A , Zanier U , Saely CH , Simma B.

Pediatr Neurol , , 13 Dec Cited by: 12 articles PMID: Haslbeck M. Z Gesamte Inn Med , 48 3 , 01 Mar Cited by: 0 articles PMID: Hajas G , Kissova V , Tirpakova A. Pediatr Diabetes , 17 8 , 29 Mar Cited by: 13 articles PMID: Nelson D , Mah JK , Adams C , Hui S , Crawford S , Darwish H , Stephure D , Pacaud D.

Pediatr Diabetes , 7 6 , 01 Dec Cited by: 31 articles PMID: Contact us. Europe PMC requires Javascript to function effectively.

Recent Activity. Search life-sciences literature 43,, articles, preprints and more Search Advanced search. This website requires cookies, and the limited processing of your personal data in order to function.

Neuropathy Diabetuc damage to the nerves neuropahty the peripheral nervous system. Diabetes Diabeyic the most common cause Diabeticc neuropathy. It most Diabwtic Diabetic neuropathy in children Sweet potato fries nerves to the Diabetic neuropathy in children and hands, but any nerves can be involved, including those that control internal organs autonomic nerves. Up to half of all people with diabetes develop neuropathy during the course of their disease. There is no cure. Management aims to ease symptoms and reduce the risk of further complications. Most people with diabetic neuropathy are unaware that they have nerve damage, until it is picked up on routine screening by their doctor.